Annual Total Debt
$14.23 M
-$5.89 M-29.29%
December 31, 2023
Summary
- As of February 8, 2025, SEEL annual total debt is $14.23 million, with the most recent change of -$5.89 million (-29.29%) on December 31, 2023.
- During the last 3 years, SEEL annual total debt has risen by +$4.50 million (+46.32%).
- SEEL annual total debt is now -29.29% below its all-time high of $20.12 million, reached on December 31, 2022.
Performance
SEEL Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Debt
$10.16 M
-$2.98 M-22.68%
June 30, 2024
Summary
- As of February 8, 2025, SEEL quarterly total debt is $10.16 million, with the most recent change of -$2.98 million (-22.68%) on June 30, 2024.
- Over the past year, SEEL quarterly total debt has dropped by -$6.75 million (-39.92%).
- SEEL quarterly total debt is now -52.53% below its all-time high of $21.40 million, reached on September 30, 2022.
Performance
SEEL Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Debt Formula
Total Debt = Short Term Debt + Long Term Debt
SEEL Total Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -29.3% | -39.9% |
| 3 y3 years | +46.3% | -49.5% |
| 5 y5 years | +100.0% | +100.0% |
SEEL Total Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -29.3% | at low | -52.5% | at low |
| 5 y | 5-year | -29.3% | -100.0% | -52.5% | -100.0% |
| alltime | all time | -29.3% | -100.0% | -52.5% | -100.0% |
Seelos Therapeutics Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2024 | - | $10.16 M(-22.7%) |
| Mar 2024 | - | $13.14 M(-7.7%) |
| Dec 2023 | $14.23 M(-29.3%) | $14.23 M(-15.8%) |
| Sep 2023 | - | $16.91 M(+10.2%) |
| Jun 2023 | - | $15.34 M(-8.6%) |
| Mar 2023 | - | $16.78 M(-16.6%) |
| Dec 2022 | $20.12 M(+6.1%) | $20.12 M(-6.0%) |
| Sep 2022 | - | $21.40 M(+11.0%) |
| Jun 2022 | - | $19.27 M(+0.4%) |
| Mar 2022 | - | $19.19 M(+1.2%) |
| Dec 2021 | $18.96 M(+95.0%) | $18.96 M(>+9900.0%) |
| Sep 2021 | - | $51.00 K(-28.2%) |
| Jun 2021 | - | $71.00 K(-98.7%) |
| Mar 2021 | - | $5.62 M(-42.2%) |
| Dec 2020 | $9.72 M(>+9900.0%) | $9.72 M(+6515.0%) |
| Sep 2020 | - | $147.00 K(0.0%) |
| Jun 2020 | - | $147.00 K(>+9900.0%) |
| Mar 2020 | - | $0.00(0.0%) |
| Dec 2019 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2019 | - | $0.00(0.0%) |
| Jun 2019 | - | $0.00(0.0%) |
| Mar 2019 | - | $0.00(0.0%) |
| Dec 2018 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2018 | - | $0.00(0.0%) |
| Jun 2018 | - | $0.00(0.0%) |
| Mar 2018 | - | $0.00(0.0%) |
| Dec 2017 | $0.00(-100.0%) | $0.00(0.0%) |
| Sep 2017 | - | $0.00(0.0%) |
| Jun 2017 | - | $0.00(0.0%) |
| Mar 2017 | - | $0.00(-100.0%) |
| Dec 2016 | $6.65 M(-29.3%) | $6.65 M(-9.8%) |
| Sep 2016 | - | $7.37 M(-8.6%) |
| Jun 2016 | - | $8.07 M(-7.7%) |
| Mar 2016 | - | $8.75 M(-7.0%) |
| Dec 2015 | $9.40 M(+96.7%) | $9.40 M(-4.8%) |
| Sep 2015 | - | $9.88 M(+102.7%) |
| Jun 2015 | - | $4.87 M(+1.0%) |
| Mar 2015 | - | $4.83 M(+1.0%) |
| Dec 2014 | $4.78 M(+83.8%) | $4.78 M(+297.3%) |
| Sep 2014 | - | $1.20 M(+1.9%) |
| Jun 2014 | - | $1.18 M(-55.6%) |
| Mar 2014 | - | $2.66 M(+2.3%) |
| Dec 2013 | $2.60 M(-23.8%) | $2.60 M(+2.2%) |
| Sep 2013 | - | $2.54 M(+2.3%) |
| Jun 2013 | - | $2.49 M(-26.7%) |
| Mar 2013 | - | $3.39 M(-0.6%) |
| Dec 2012 | $3.41 M(-14.7%) | $3.41 M(-14.7%) |
| Sep 2012 | - | $4.00 M(0.0%) |
| Jun 2012 | - | $4.00 M(0.0%) |
| Mar 2012 | - | $4.00 M(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2011 | $4.00 M(-11.8%) | $4.00 M(0.0%) |
| Sep 2011 | - | $4.00 M(0.0%) |
| Jun 2011 | - | $4.00 M(-8.0%) |
| Mar 2011 | - | $4.35 M(-4.1%) |
| Dec 2010 | $4.53 M(-70.3%) | $4.53 M(+0.3%) |
| Sep 2010 | - | $4.52 M(-0.1%) |
| Jun 2010 | - | $4.53 M(-67.7%) |
| Mar 2010 | - | $14.03 M(-8.0%) |
| Dec 2009 | $15.26 M(+225.3%) | $15.26 M(+325.0%) |
| Sep 2009 | - | $3.59 M(-17.3%) |
| Jun 2009 | - | $4.34 M(-7.5%) |
| Mar 2009 | - | $4.69 M(0.0%) |
| Dec 2008 | $4.69 M(+84.7%) | $4.69 M(-18.4%) |
| Sep 2008 | - | $5.75 M(0.0%) |
| Jun 2008 | - | $5.75 M(+119.8%) |
| Mar 2008 | - | $2.62 M(+3.0%) |
| Dec 2007 | $2.54 M(-47.9%) | $2.54 M(+29.0%) |
| Sep 2007 | - | $1.97 M(+1.6%) |
| Jun 2007 | - | $1.94 M(-60.5%) |
| Mar 2007 | - | $4.90 M(+0.7%) |
| Dec 2006 | $4.87 M(-22.5%) | $4.87 M(-19.1%) |
| Sep 2006 | - | $6.02 M(-0.7%) |
| Jun 2006 | - | $6.06 M(-1.1%) |
| Mar 2006 | - | $6.13 M(-2.5%) |
| Dec 2005 | $6.29 M(-8.6%) | $6.29 M(-1.4%) |
| Sep 2005 | - | $6.38 M(-2.3%) |
| Jun 2005 | - | $6.53 M(-2.4%) |
| Mar 2005 | - | $6.69 M(-2.7%) |
| Dec 2004 | $6.88 M(-11.6%) | $6.88 M(-3.3%) |
| Sep 2004 | - | $7.11 M(-3.1%) |
| Jun 2004 | - | $7.34 M(-2.9%) |
| Mar 2004 | - | $7.56 M(-2.8%) |
| Dec 2003 | $7.78 M(+28.7%) | $7.78 M(+155.8%) |
| Sep 2003 | - | $3.04 M(-19.9%) |
| Jun 2003 | - | $3.80 M(-26.7%) |
| Mar 2003 | - | $5.18 M(-14.2%) |
| Dec 2002 | $6.04 M(+497.0%) | $6.04 M(+4.8%) |
| Sep 2002 | - | $5.76 M(+5.1%) |
| Jun 2002 | - | $5.49 M(+481.8%) |
| Mar 2002 | - | $942.80 K(-6.8%) |
| Dec 2001 | $1.01 M(>+9900.0%) | $1.01 M(+22.9%) |
| Sep 2001 | - | $823.20 K(>+9900.0%) |
| Jun 2001 | - | $0.00(0.0%) |
| Mar 2001 | - | $0.00(0.0%) |
| Dec 2000 | $0.00(-100.0%) | $0.00(0.0%) |
| Sep 2000 | - | $0.00(0.0%) |
| Jun 2000 | - | $0.00(0.0%) |
| Mar 2000 | - | $0.00 |
| Dec 1999 | $100.00 K(>+9900.0%) | - |
| Dec 1998 | $0.00(-100.0%) | - |
| Dec 1997 | $2.57 M | - |
FAQ
- What is Seelos Therapeutics annual total debt?
- What is the all time high annual total debt for Seelos Therapeutics?
- What is Seelos Therapeutics annual total debt year-on-year change?
- What is Seelos Therapeutics quarterly total debt?
- What is the all time high quarterly total debt for Seelos Therapeutics?
- What is Seelos Therapeutics quarterly total debt year-on-year change?
What is Seelos Therapeutics annual total debt?
The current annual total debt of SEEL is $14.23 M
What is the all time high annual total debt for Seelos Therapeutics?
Seelos Therapeutics all-time high annual total debt is $20.12 M
What is Seelos Therapeutics annual total debt year-on-year change?
Over the past year, SEEL annual total debt has changed by -$5.89 M (-29.29%)
What is Seelos Therapeutics quarterly total debt?
The current quarterly total debt of SEEL is $10.16 M
What is the all time high quarterly total debt for Seelos Therapeutics?
Seelos Therapeutics all-time high quarterly total debt is $21.40 M
What is Seelos Therapeutics quarterly total debt year-on-year change?
Over the past year, SEEL quarterly total debt has changed by -$6.75 M (-39.92%)